The Nurse View: Evolution of Anti-HER2 Therapies in Gastroesophageal Adenocarcinoma

Do you know what to test for in your patients with CRC? Credit available for this activity expires: 3/30/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/expanding-actionability-crucial-biomarkers-your-community-2026a10009al?ecd=bdc_podcast_libsyn_mscped

Do you know the next best steps for a patient with persistent gastroesophageal reflux disease (GERD) symptoms? Credit available for this activity expires: 3/30/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/identifying-suboptimally-managed-erosive-esophagitis-2026a100096o?ecd=bdc_podcast_libsyn_mscped

Get the latest updates on HER2-mutated NSCLC. Credit available for this activity expires: 3/30/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/steps-personalized-and-collaborative-decision-making-her2-2026a10007ur?ecd=bdc_podcast_libsyn_mscped

Are you familiar with the most common treatment-related events of emerging HER2-targeted therapies for gastroesophageal adenocarcinoma (GEA)? Credit available for this activity expires: 3/30/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/nurse-view-evolution-anti-her2-therapies-gastroesophageal-2026a100096j?ecd=bdc_podcast_libsyn_mscpedu

Learn PFIC genetics, case-based management, and family counseling with Dr Kushner. Credit available for this activity expires: 03/18/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/progressive-familial-intrahepatic-cholestasis-case-community-2026a100070f?ecd=bdc_podcast_libsyn_mscpedu

A quick take on what's on the horizon for Dravet syndrome treatment Credit available for this activity expires: 03/17/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/rapid-reports-dravet-syndrome-synthesizing-pipeline-2026a10007ux?ecd=bdc_podcast_libsyn_mscpedu

Bronchiectasis affects up to 500,000 Americans and requires a personalized treatment approach to prevent serious complications. Credit available for this activity expires: 03/13/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/demystifying-bronchiectasis-rethinking-standards-care-2026a10006kz?ecd=bdc_podcast_libsyn_mscpedu

Do you know how many different types of anti-HER2 therapies are in clinical trials for gastroesophageal adenocarcinoma (GEA)? Credit available for this activity expires: 02/27/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/breaking-ground-gastroesophageal-adenocarcinoma-first-line-2026a10005tj?ecd=bdc_podcast_libsyn_mscpedu

Transforming CLL care: measurable residual disease (MRD) guided stopping, smart triplet selection, and next‑gen Bruton tyrosine kinase (BTKs)—practical insights.   Credit available for this activity expires: 02/19/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/chronic-lymphocytic-leukemia-cll-review-combination-2026a10004ku?ecd=bdc_podcast_libsyn_mscpedu    

Are you up to date on the management of extensive-stage small cell lung cancer (ES-SCLC)? Credit available for this activity expires: 2/20/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/quick-talk-es-sclc-what-community-clinicians-need-know-now-2026a100055m?ecd=bdc_podcast_libsyn_mscpedu